David S. Mandell (PSC Research Associate), Molly Candon (PARC Research Associate) and co-author write about the problems with buprenorphine waivers and its effect on opioid treatments. Read more at the Penn Center for Mental Health
David S. Mandell (PSC Research Associate), Molly Candon (PARC Research Associate) and co-author write about the problems with buprenorphine waivers and its effect on opioid treatments. Read more at the Penn Center for Mental Health